Skip to main content
AAO-HNSF 2024 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Expert Lectures

Endocrine Surgery

The Central Neck and Beyond: Strategies in Advanced and Recurrent Thyroid Cancer

Sunday, September 29, 2024
8:00 AM – 9:00 AM EDT
Location: MBCC, 209
CME/MOC Credit: 1
Disclosure(s):
Sarah L. Rohde, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

James l. Netterville, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: Invasive well-differentiated thyroid cancer is relatively common, yet there exist few guidelines to aid in surgical disease management. The ATA guidelines provide little guidance in surgical decision-making especially with regards to recurrent or invasive disease. In this course, we will first examine the common symptoms associated with invasive thyroid cancer. The importance of prior laryngeal examination and guidelines for the use of advanced pre operative imaging will be discussed. The important anatomic relationships in the paratracheal space will be explored. how these relationships are altered in complex and revision surgery will be examined. The common locations of disease involvement including management of the strap muscles, recurrent laryngeal nerve, trachea, larynx, esophagus and major vessels will be addressed. Multiple ways to approach and identify relevant anatomy will be reviewed with application to not only revision surgery, but also complex initial surgeries.

Learning Objectives:

  1. To recognize common symptoms associated with invasive thyroid cancer.
  2. To understand the anatomical considerations in the paratracheal space and apply those to complex thyroidectomy, revision thyroidectomy, and revision cancer surgery.
  3. To implement strategies to safely identify normal structures and achieve gross total resection in invasive thyroid cancer.

    Lead Presenter(s)

  • Sarah L. Rohde, MD

    Associate Professor
    Vanderbilt University Medical Center
    Nashville, Tennessee, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

    • Co-Presenter(s)

  • James l. Netterville, MD

    Professor of Head and Neck Oncology, Mark C. Smith Chair in Head and Neck Oncologic Services
    Vanderbilt University Medical Center
    Nashville, TN, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.